share_log

Mammoth Energy Services, Inc. (TUSK) Q3 2024 Earnings Call Transcript Summary

Futu News ·  Nov 2 18:16  · Conference Call

The following is a summary of the Mammoth Energy Services, Inc. (TUSK) Q3 2024 Earnings Call Transcript:

Financial Performance:

  • Mammoth Energy reported a Q3 2024 revenue of $40 million, down from $51.5 million in Q2 2024 due to continued activity softness in natural gas basins.

  • The company experienced a net loss of $23.4 million, with a loss per share of $0.50.

  • Adjusted EBITDA for Q3 2024 was negative $6.4 million.

Business Progress:

  • Mammoth Energy has paid off its term credit facility of $50.9 million using the settlement funds, rendering the company debt-free.

  • Mammoth Energy focuses on growth in its infrastructure business, investing in T&D and engineering, and on modernizing its fleet with Tier 4 dual-fuel pump upgrades.

  • The company deployed about one-third of its crews in response to storm events, which impacted its infrastructure service business.

Opportunities:

  • The company sees an opportunity to grow its infrastructure business further, supported by the Infrastructure Investment and Jobs Act funds.

  • Plans to invest in pressure pumping assets to upgrade technology and improve efficiency in response to anticipated demand increases in 2025.

Risks:

  • The well completion services division remains challenged due to prolonged industry softness and low natural gas prices.

  • Market conditions predicted to impact activity levels through the first half of 2025, with only a potential recovery in the latter half.

Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment